Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Filings indexed 1,621 across all filing types
Latest filing 2023-03-08 Director's Dealing
Country TW Taiwan
Listing TW 1720

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
112年02月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, executives, and their related parties. It includes data on shares held at appointment, changes during the month, and current holdings. This type of document is typical of insider shareholding disclosures or director dealings. There is no indication of financial results, earnings, management discussion, or report announcements. The content is focused on personal share transactions and holdings by company insiders, which aligns with the definition of Director's Dealing filings.
2023-03-08 Chinese
112年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and major shareholders, with specific numbers of shares held, pledged shares, and related party holdings. It is focused on insider share ownership disclosures rather than financial results, management changes, or meeting materials. There is no indication of a report publication or certification. The content matches the definition of a Director's Dealing report, which involves reporting personal share transactions or holdings by company directors and executives. The document is relatively short (2407 characters) but contains substantive insider shareholding data, not just an announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-03-08 Chinese
公告本公司董事長辭任
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's board of directors, specifically the resignation of the chairman. It includes details such as the resignation date, the name of the outgoing chairman, and notes about the upcoming board meeting to appoint a new chairman. There are no financial statements, earnings data, or report attachments. The content fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2023-03-06 Chinese
112年2月24日內部人設質解質
Director's Dealing Classification · 95% confidence The document is a short tabular report showing a pledge or release of shares by a company director (董事長本人) with specific dates and share quantities. It reports a personal share transaction by a company director, which fits the definition of Director's Dealing (DIRS). The document length is very short (318 characters), and it contains specific insider share transaction data, not a general announcement or report publication. Therefore, it is classified as DIRS with high confidence.
2023-03-01 Chinese
112年1月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document contains financial data related to loan balances and guarantee information for the company and its subsidiaries, presented in a tabular format with monetary amounts. It is a short document (611 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial status rather than a full report or announcement of a report. The content fits best under a general regulatory announcement category rather than a specific report type like Annual Report or Interim Report.
2023-02-09 Chinese
112年1月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month (January 112th year of the Republic of China calendar, equivalent to 2023) and compares it to the previous year. The document is short (766 characters) and provides substantive financial data rather than just an announcement or a link to a report. It is not a full annual or interim report but a periodic financial summary. Given the presence of monthly and cumulative revenue data and the nature of the content, this fits best as an Interim / Quarterly Report (IR).
2023-02-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.